Anti-Cytokeratin 7 antibody [KRT7/1499R]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Cytokeratin 7 antibody. Suitable for IHC-P, Flow Cyt, WB and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human KRT7.
View Alternative Names
SCL, KRT7, Cytokeratin-7, Keratin-7, Sarcolectin, Type-II keratin Kb7, CK-7, K7, CK7
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 7 antibody [KRT7/1499R] (AB218440)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded human oviduct tissue labeling Cytokeratin 7 with ab218440 at 1 μg/ml.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-Cytokeratin 7 antibody [KRT7/1499R] (AB218440)
Flow Cytometric analysis of PFA-fixed HeLa cells using ab218440 followed by Goat anti-rabbit IgG-CF488 (Blue); Isotype control (Red).
- WB
Supplier Data
Western blot - Anti-Cytokeratin 7 antibody [KRT7/1499R] (AB218440)
Western blot analysis labeling Cytokeratin 7 with ab218440 at 1 ug/ml.
All lanes:
Western blot - Anti-Cytokeratin 7 antibody [KRT7/1499R] (ab218440) at 1 µg/mL
All lanes:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate
Predicted band size: 51 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Cell death discovery 8:132 PubMed35338123
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com